Riverbridge Partners LLC Sells 3,372 Shares of Chemed Corporation $CHE

Riverbridge Partners LLC trimmed its position in Chemed Corporation (NYSE:CHE) by 6.2% during the 1st quarter, Holdings Channel reports. The institutional investor owned 50,747 shares of the company’s stock after selling 3,372 shares during the period. Riverbridge Partners LLC’s holdings in Chemed were worth $19,169,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Geneos Wealth Management Inc. increased its position in shares of Chemed by 330.4% in the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after acquiring an additional 76 shares during the period. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Chemed by 67.0% during the second quarter. Arrowstreet Capital Limited Partnership now owns 11,365 shares of the company’s stock worth $5,534,000 after purchasing an additional 4,560 shares during the period. Marshall Wace LLP bought a new stake in shares of Chemed in the second quarter worth about $579,000. Brown Advisory Inc. grew its stake in shares of Chemed by 36.9% in the second quarter. Brown Advisory Inc. now owns 549 shares of the company’s stock worth $267,000 after purchasing an additional 148 shares during the last quarter. Finally, Cerity Partners LLC increased its holdings in Chemed by 237.7% during the 2nd quarter. Cerity Partners LLC now owns 4,451 shares of the company’s stock valued at $2,165,000 after purchasing an additional 3,133 shares during the period. 95.85% of the stock is currently owned by institutional investors.

Chemed Price Performance

CHE stock opened at $444.20 on Wednesday. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $562.77. The company has a market cap of $5.90 billion, a P/E ratio of 24.21, a PEG ratio of 1.63 and a beta of 0.54. The firm has a 50-day moving average of $422.01 and a 200 day moving average of $424.31. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, beating the consensus estimate of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The business had revenue of $657.51 million for the quarter, compared to analysts’ expectations of $659.22 million. During the same period in the previous year, the firm posted $5.63 EPS. The business’s revenue was up 1.6% on a year-over-year basis. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, sell-side analysts forecast that Chemed Corporation will post 22.3 EPS for the current year.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th were paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date was Thursday, May 28th. Chemed’s dividend payout ratio (DPR) is presently 13.08%.

Analyst Upgrades and Downgrades

A number of research firms have commented on CHE. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Royal Bank Of Canada boosted their target price on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research note on Monday, April 27th. Oppenheimer decreased their target price on Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a report on Friday, February 27th. Finally, Wall Street Zen lowered Chemed from a “buy” rating to a “hold” rating in a research note on Monday, June 8th. Two research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $501.50.

Insider Activity at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $421.13, for a total transaction of $842,260.00. Following the sale, the chief executive officer directly owned 90,219 shares in the company, valued at $37,993,927.47. The trade was a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Andrea R. Lindell sold 1,347 shares of the company’s stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the completion of the sale, the director directly owned 4,578 shares in the company, valued at approximately $2,047,876.74. The trade was a 22.73% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 3.33% of the company’s stock.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.